Investing in a down market
Bristol repurchased 11.3 mil. shares during the first quarter for $700 mil. in cash, or an average of about $62 per share. The stock is currently trading at about $57 per share. Bristol paid a total of $5.3 bil. to buy back 93 mil. shares during 1998-2000 (an average of $57 per share)
You may also be interested in...
Procter & Gamble is comfortable with its position as a "niche" player in the pharmaceutical industry over the short term, CEO A.G. Lafley said during a May 21 analysts meeting discussing the acquisition of Clairol from Bristol-Myers Squibb.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011